跳至主要内容
临床试验/JPRN-UMIN000005208
JPRN-UMIN000005208已完成1 期

Clinical study of administration of alpha-GalactosylCeramide-pulsed DCs by bronchoscopy in patients with either advanced or recurrent non-small cell lung cancer (NSCLC) - Clinical study of administration of alpha-GalactosylCeramide-pulsed DCs by the bronchoscopy

Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University0 个研究点目标入组 18 人开始时间: 2011年3月8日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who have: uncontrolled diabetes mellitus, pulmonary fibrosis, and/or infection; synchronous multiple cancer; a history of hepatitis; a positive response for hepatitis B surface antigen, hepatitis C virus, or human immunodeficiency virus (HIV), or human T-lymphotrophic virus antibodies; serious cardiac diseases; pregnancy or lactation; autoimmune diseases; been judged to be inappropriate to practice in this study by principle investigator

研究者

发起方
Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University

相似试验